Long-term prescribing of nitrofurantoin for urinary tract infections (UTI) in veterans with spinal cord injury (SCI).
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents
/ administration & dosage
Anti-Infective Agents, Urinary
/ administration & dosage
Drug Prescriptions
Female
Hospitals, Veterans
/ trends
Humans
Male
Middle Aged
Nitrofurantoin
/ administration & dosage
Retrospective Studies
Spinal Cord Injuries
/ drug therapy
Time Factors
Urinary Tract Infections
/ drug therapy
Veterans
Young Adult
Antibiotic prophylaxis
Nitrofurantoin
Outcome assessment
Physicians
Practice patterns
Spinal cord injuries
Urinary tract infections
Journal
The journal of spinal cord medicine
ISSN: 2045-7723
Titre abrégé: J Spinal Cord Med
Pays: England
ID NLM: 9504452
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
pubmed:
10
7
2018
medline:
18
4
2020
entrez:
10
7
2018
Statut:
ppublish
Résumé
To evaluate the impact of long-term nitrofurantoin for UTI prophylaxis in veterans with SCI. Matched pairs study. Veterans cared for at VA facilities from 10/1/2012-9/30/2013. Veterans. n/a. UTI, positive urine cultures, resistant cultures. Cases receiving long-term nitrofurantoin (≥90 days supply) were matched to controls by facility. Controls were patients who did not receive long-term nitrofurantoin with a history of ≥3 positive urine cultures and at least one diagnosis of UTI or asymptomatic bacteriuria in the previous year. 122 SCI cases were identified and matched to 196 controls. After adjusting for differences in baseline demographic characteristics, UTIs were less frequent in cases (OR = 0.60 [95% CI 0.44-0.72]). Cases had a greater mean number of days between positive urine cultures as compared to controls (<0.0001). Cases were more likely to have isolates resistant to nitrofurantoin (P ≤ 0.0001); however, the frequency of multi-drug resistant organisms isolated from the urine was not significantly different. Long-term prescription of nitrofurantoin may reduce UTIs in veterans with SCI and there is no evidence that it promotes multi-drug resistance. Future prospective studies should be conducted prior to incorporating routine use of long-term nitrofurantoin into clinical care.
Identifiants
pubmed: 29985783
doi: 10.1080/10790268.2018.1488096
pmc: PMC6718139
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Infective Agents, Urinary
0
Nitrofurantoin
927AH8112L
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
485-493Références
Paraplegia. 1984 Apr;22(2):61-5
pubmed: 6462734
Arch Phys Med Rehabil. 1999 Nov;80(11):1429-34
pubmed: 10569437
J Urol. 2000 Oct;164(4):1285-9
pubmed: 10992382
J Antimicrob Chemother. 2006 Apr;57(4):784-8
pubmed: 16473921
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD004201
pubmed: 22895939
Osteoporos Int. 2016 Oct;27(10):3011-21
pubmed: 27230522
J Spinal Cord Med. 2013 Sep;36(5):492-8
pubmed: 23941797
Antibiot Chemother (1971). 1978;25:233-52
pubmed: 352255
Antimicrob Agents Chemother. 2002 Aug;46(8):2540-5
pubmed: 12121930
Arch Phys Med Rehabil. 1995 Mar;76(3):272-80
pubmed: 7717822
Clin Infect Dis. 2000 Mar;30(3):425-32
pubmed: 10722423
Am J Phys Med Rehabil. 2000 Nov-Dec;79(6):526-35
pubmed: 11083303
J Am Paraplegia Soc. 1992 Jul;15(3):194-204
pubmed: 1500945
Clin Infect Dis. 2010 Mar 1;50(5):625-63
pubmed: 20175247
JAMA Intern Med. 2015 Jul;175(7):1120-7
pubmed: 26010222
J Urol. 1994 Jan;151(1):105-8
pubmed: 8254783
Saudi Pharm J. 2014 Sep;22(4):303-8
pubmed: 25161373
BJU Int. 2008 Dec;102(11):1634-7
pubmed: 18657135
J Urol. 1980 Mar;123(3):364-6
pubmed: 6244414
J Urol. 1985 Sep;134(3):514-7
pubmed: 3897577
Infect Control Hosp Epidemiol. 2008 Mar;29(3):234-42
pubmed: 18248306
BMC Geriatr. 2012 Nov 23;12:73
pubmed: 23176555
Evid Rep Technol Assess (Summ). 1999 Jan;(6):1-3
pubmed: 11487801
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Antimicrob Chemother. 1998 Sep;42(3):363-71
pubmed: 9786476
Paraplegia. 1992 Sep;30(9):617-30
pubmed: 1408338
Spinal Cord. 2016 Nov;54(11):1001-1009
pubmed: 27001131
J Spinal Cord Med. 2018 Mar;41(2):199-207
pubmed: 28198662
Antimicrob Agents Chemother. 2012 Apr;56(4):2181-3
pubmed: 22252813
Arch Phys Med Rehabil. 2002 Jan;83(1):129-38
pubmed: 11782843